Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
36.24 USD | +0.67% | +29.19% | +76.53% |
12:52pm | Oppenheimer Initiates Cartesian Therapeutics With Outperform Rating, $50 Price Target | MT |
May. 24 | Mizuho Securities Starts Cartesian Therapeutics With Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+76.53% | 641M | |
+15.40% | 121B | |
+13.02% | 107B | |
-3.36% | 24.82B | |
+1.40% | 22.48B | |
-9.84% | 18.32B | |
-42.28% | 16.33B | |
-16.83% | 15.31B | |
+4.09% | 14.08B | |
+27.36% | 11.74B |
- Stock Market
- Equities
- RNAC Stock
- News Cartesian Therapeutics, Inc.
- Needham Adjusts Price Target on Selecta Biosciences to $4 From $5, Maintains Buy Rating